sucrose and ao 128

sucrose has been researched along with ao 128 in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (66.67)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Daimon, M; Fukase, N; Igarashi, M; Manaka, H; Sasaki, H; Sugiyama, K; Takahashi, H; Tominaga, M; Yamatani, K1
Goto, Y; Ikeda, H; Matsuo, T; Odaka, H; Ohyama, T; Yamada, K1
Akiyoshi, M; Fujitani, S; Ikenoue, T; Kondo, N; Maki, T; Okazaki, K; Tsuchiya, Y1
Hiai, H; Ihara, Y; Ikeda, H; Odaka, H; Seino, Y; Tanaka, T; Toyokuni, S; Uchida, K; Yamada, Y1
Kitahara, Y; Miura, K; Mori, Y; Tajima, N1

Trials

1 trial(s) available for sucrose and ao 128

ArticleYear
An alpha-glucosidase inhibitor, AO-128, retards carbohydrate absorption in rats and humans.
    Diabetes research and clinical practice, 1995, Volume: 28, Issue:2

    Topics: Adolescent; Adult; Animals; Blood Glucose; Cross-Over Studies; Cyclohexanols; Dietary Carbohydrates; Eating; Enzyme Inhibitors; Glycoside Hydrolase Inhibitors; Humans; Hydrogen; Hyperglycemia; Hyperinsulinism; Intestinal Absorption; Male; Rats; Rats, Sprague-Dawley; Respiration; Single-Blind Method; Sucrose

1995

Other Studies

5 other study(ies) available for sucrose and ao 128

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Differences in glucagon-like peptide-1 and GIP responses following sucrose ingestion.
    Diabetes research and clinical practice, 1992, Volume: 15, Issue:3

    Topics: Adult; Blood Glucose; Cyclohexanols; Gastric Inhibitory Polypeptide; Glucagon; Glucagon-Like Peptide 1; Glucose; Glycoside Hydrolase Inhibitors; Humans; Infusions, Intravenous; Insulin; Insulin Secretion; Kinetics; Male; Peptide Fragments; Protein Precursors; Reference Values; Sucrose; Time Factors

1992
Effect of a new hypoglycemic agent, A-4166 [(-)-N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine], on postprandial blood glucose excursion: comparison with voglibose and glibenclamide.
    Biological & pharmaceutical bulletin, 1997, Volume: 20, Issue:4

    Topics: Animals; Blood Glucose; Cyclohexanes; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Glucose; Glyburide; Hypoglycemic Agents; Inositol; Insulin; Male; Nateglinide; Phenylalanine; Postprandial Period; Rats; Rats, Wistar; Sucrose

1997
Hyperglycemia causes oxidative stress in pancreatic beta-cells of GK rats, a model of type 2 diabetes.
    Diabetes, 1999, Volume: 48, Issue:4

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Aldehydes; Animals; Blood Glucose; Deoxyguanosine; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Hyperglycemia; Immunohistochemistry; Inositol; Insulin; Islets of Langerhans; Oxidative Stress; Proteins; Rats; Rats, Inbred Strains; Solutions; Sucrose

1999
Comparison of voglibose and nateglinide for their acute effects on insulin secretion and free fatty acid levels in OLETF rat portal blood after sucrose loading.
    Endocrine, 2004, Volume: 23, Issue:1

    Topics: Animals; Area Under Curve; Blood Glucose; Cyclohexanes; Diabetes Mellitus, Type 2; Disease Models, Animal; Enzyme Inhibitors; Fatty Acids, Nonesterified; Hypoglycemic Agents; Inositol; Insulin; Insulin Secretion; Male; Nateglinide; Phenylalanine; Portal Vein; Postprandial Period; Rats; Rats, Inbred OLETF; Secretory Rate; Sucrose

2004